Xenon Pharmaceuticals Inc

XENENASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

96.8M

on 2026-06-30, from 75.5M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3ASR of 2024-08-09. Not read yet. S-3ASR ↗

$400.0M

Jefferies, agreement of 2020-08-06. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

2.93M

Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $0.0001. 10-Q ↗

Cash

11 quarters

$930.7M on 2026-06-30 ÷ $84.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-03-12	Public offering	10,526,317	$57.00	$650.0M	424B5 ↗